Loading clinical trials...
Loading clinical trials...
Evaluation of the Clinical Consistency and Analytical Robustness of Immunobiogram® as an In Vitro Diagnostics Biotechnological Tool to Help Decision-making in Adjustment of Immunosuppressant Therapy for Renal Transplant
Conditions
Interventions
NA-Observational only
Locations
1
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
June 1, 2018
Primary Completion Date
April 30, 2019
Completion Date
May 31, 2019
Last Updated
December 29, 2023
NCT07415421
NCT06958796
NCT07294547
NCT07224763
NCT06972069
NCT05234463
Lead Sponsor
Biohope Scientific Solutions for Human Health, S.L.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions